Therefore, we speculated that if in AD-affected cells we would be able (by using LR inhibitor) to reverse the subcellular localization of the APP and, consequently, its trafficking to that of healthy cells, we should have observed a restoring of cellular phenotype resembling one of healthy conditions, including mitochondrial network phenotype. This evidence concerns the gene APP and Alzheimer disease.